Advertisement

Topics

Array BioPharma Climbs Off Worst Levels But Continues To Post Notable Loss

13:36 EDT 20 Mar 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Array BioPharma (ARRY) has climbed well off its worst levels but continues to post a notable loss in afternoon trading on Monday. Shares of Array are currently down by 5.3 p...

Original Article: Array BioPharma Climbs Off Worst Levels But Continues To Post Notable Loss

NEXT ARTICLE

More From BioPortfolio on "Array BioPharma Climbs Off Worst Levels But Continues To Post Notable Loss"

Quick Search
Advertisement
 

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...